Clinical Trial Update: Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing five versus six radiation therapy fractions per week for head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Five versus Six Fractions per Week Radiotherapy

Snippet

Sponsor: International Atomic Energy Agency | Conditions: Head and Neck Cancer | Phase 3 | Status: COMPLETED